Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.

CVNA is benefiting from strong retail sales, solid ADESA integration and improved operational efficiency.

IRBT is set to benefit from solid product offerings, innovation capabilities and operational initiatives.

Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the fourth quarter of...

By Saima Nawaz Pakistan’s 2024 witnessed economic uncertainties, political instability, social unrest and the resurgence of terrorism, marking a...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong demand for its GLP-1...

AWI's fourth-quarter results reflect strong AUV growth, higher sales volume and contributions from recent acquisitions.

The rubber sector's resurgence is characterised by strong fundamentals and strategic opportunities, positioning it well for future growth in the...

HWM gains from strength across its end markets, solid liquidity position and shareholder-friendly policies.

CRI's Q4 results show marginal sales growth, but profit falls due to higher freight costs, intense promotional competition and macroeconomic...